|
International HIFU is a healthcare development company and medical device distributor committed to creating a new standard for Prostate cancer treatment with high intensity focused ultrasound (HIFU) therapy. International HIFU works with hospitals and medical centers in countries where HIFU is authorized for treating prostate cancer, including Canada, Mexico, the Dominican Republic and the Bahamas, to make the non invasive therapy available.
Click here to see where HIFU is available.
MISSION
To fundamentally improve the way that prostate cancer care is delivered and to drastically improve patient quality of life while improving efficacy.
ADDRESS
International HIFU
801 E. Morehead St
Suite 201
Charlotte, NC 28202
Toll Free from US & Canada: 1-866-553-1629
704-332-4308
704-332-5628 - fax
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
MAP TO OUR LOCATION
International HIFU, is the exclusive distributor of the Sonablate 500 in North, Central and South America and the funding source for Phase II-III U.S. clinical trials for the device. The device was created by Focus Surgery Inc. of Indianapolis and is manufactured by Misonix Inc. (NASDAQ: MSON) of Farmingdale, NY. Misonix holds a minority ownership equity position in Focus Surgery and exclusive distribution rights in Europe. Takai Hospital Supply Ltd. (THS) of Tokyo also holds a minority equity ownership position in Focus Surgery and is the exclusive distributor in Asia. International HIFU is now enrolling various hospitals for Phase II-III trials.
|
